Kweichow Moutai Investment Quality Review (600519.SH)

Data timestamp: 2026-08-03 22:13 UTC
Quality score: 83/100
Valuation position: current price/base FV 2.87
Final signal: WATCHLIST

Core Conclusion

Moutai is a high-quality franchise but not an attractive stock at this price. CNY1,358.98 is 2.87x base FV of CNY474.27 and 3.19x conservative FV of CNY425.93. The signal remains watchlist because quality is high, while valuation is clearly stretched.

Business Breakdown

Five-year revenue CAGR is 1.1%, with latest-year revenue of CNY172.05bn. The brand, scarcity, margins, and balance sheet remain exceptional, but slow growth and premium-spirits cycle risk force a sober fair-value anchor.

Business Quality

The 83/100 score reflects strong franchise economics, returns, and cash resources. Latest-year FCF was CNY58.39bn. Five-year average ROE was 32.5% and average ROIC was 31.4%. Quality does not compensate for paying almost three times base FV.

Financial Audit

Fiscal 2025 revenue was CNY172.05bn, net profit CNY82.32bn, operating cash flow CNY61.52bn, capex CNY3.13bn, and FCF CNY58.39bn. Five-year FCF/net income was 0.84 and OCF/net income was 0.90. Latest net cash was CNY51.46bn.

Valuation

The conservative case uses CNY60.43bn normalized FCF, -1.0% growth, and 8.0x, producing CNY425.93 per share. The base case uses 0.0% growth and 9.0x, producing CNY474.27. The optimistic case uses 1.5% growth and 11.9x, producing CNY616.46. Current price is above all cases.

Buy And Tracking Discipline

The action is watch, not buy. A buy requires price/base FV below 0.70, quality above 75, continued FCF durability, and no weakening in channel pricing, demand, governance, or shareholder-return discipline.

Risk Review

Risks include premium liquor demand slowdown, channel inventory, pricing pressure, policy or anti-corruption shocks, and capital allocation that does not compound per share. Weak cash conversion or cash drawdown would lower FV.

Data Sources

The memo relies on public market and financial data, company filings or investor-relations materials, ChinaBond yield data, and public FX data where applicable. This is research only, not personalized investment advice.